NASDAQ:TMCI Treace Medical Concepts (TMCI) Stock Price, News & Analysis $5.27 -0.07 (-1.31%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$5.28 +0.01 (+0.09%) As of 11/13/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Treace Medical Concepts Stock (NASDAQ:TMCI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TMCI alerts:Sign Up Key Stats Today's Range$4.95▼$5.3250-Day Range$3.87▼$5.3452-Week Range$1.17▼$5.44Volume287,803 shsAverage Volume322,132 shsMarket Capitalization$345.50 millionP/E RatioN/ADividend YieldN/APrice Target$6.17Consensus RatingHold Company Overview Treace Medical Concepts, Inc. develops and markets medical devices for foot and ankle surgery, with a focus on treatments for bunions and related deformities. Its products are designed for use by surgeons in correcting and stabilizing bones and joints in the foot. The company’s offerings include the Lapiplasty 3D Bunion Correction System, which uses specialized instruments and fixation implants to support correction of bunion deformities in three dimensions. Treace also sells systems and implants for other foot and ankle procedures, including treatments for deformities involving the midfoot and big toe. Founded in 2013 and headquartered in Ponte Vedra Beach, Florida, Treace was established by John Treace, a medical-device industry executive and the company’s founder. It serves healthcare providers in the United States and select international markets.AI Generated. May Contain Errors. Read More Treace Medical Concepts Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreTMCI MarketRank™: 3.5622542595 of 5 starsTreace Medical Concepts scored higher than 71% of companies evaluated by MarketBeat, and ranked 216th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingTreace Medical Concepts has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialTreace Medical Concepts has a consensus price target of $6.17, representing about 17.0% upside from its current price of $5.27.Amount of Analyst CoverageTreace Medical Concepts has only been the subject of 3 research reports in the past 90 days.Read more about Treace Medical Concepts' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.80) to ($0.76) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Treace Medical Concepts is -6.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Treace Medical Concepts is -6.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTreace Medical Concepts has a P/B Ratio of 5.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.60% of the float of Treace Medical Concepts has been sold short.Short Interest Ratio / Days to CoverTreace Medical Concepts has a short interest ratio ("days to cover") of 8.65.Change versus previous monthShort interest in Treace Medical Concepts has recently decreased by 6.91%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTreace Medical Concepts does not currently pay a dividend.Dividend GrowthTreace Medical Concepts does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.47 News SentimentTreace Medical Concepts has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Treace Medical Concepts this week, compared to 2 articles on an average week. Company Ownership4.3 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $246,841.00 in company stock, which represents 0.0714% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Treace Medical Concepts insiders have bought more of their company's stock than they have sold. Specifically, they have bought $246,841.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders23.42% of the stock of Treace Medical Concepts is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.08% of the stock of Treace Medical Concepts is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Treace Medical Concepts' insider trading history. Receive TMCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TMCI Stock News HeadlinesTreace Medical Concepts Shares Rise After Stifel UpgradeNovember 9, 2026 | marketscreener.comMStifel Upgrades Treace Medical Concepts to Buy From Hold, Price Target is $6.50November 9, 2026 | marketscreener.comMThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.November 15 at 1:00 AM | Porter & Company (Ad)NeuroOne Medical Technologies (NASDAQ:NMTC) & Treace Medical Concepts (NASDAQ:TMCI) Critical ReviewNovember 7, 2026 | americanbankingnews.comTreace Medical (TMCI) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | finance.yahoo.comTreace Medical Concepts, Inc. (TMCI) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | seekingalpha.comTreace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction SystemNovember 6, 2026 | markets.businessinsider.comTreace Medical Concepts Reports Third Quarter 2026 Financial ResultsNovember 6, 2026 | globenewswire.comSee More Headlines TMCI Stock Analysis - Frequently Asked Questions How have TMCI shares performed this year? Treace Medical Concepts' stock was trading at $2.45 at the beginning of 2026. Since then, TMCI shares have increased by 115.1% and is now trading at $5.27. How were Treace Medical Concepts' earnings last quarter? Treace Medical Concepts, Inc. (NASDAQ:TMCI) issued its earnings results on Friday, November, 6th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.06. The company earned $48.25 million during the quarter, compared to analysts' expectations of $47.80 million. Treace Medical Concepts had a negative trailing twelve-month return on equity of 72.99% and a negative net margin of 27.44%. Read the conference call transcript. When did Treace Medical Concepts IPO? Treace Medical Concepts (TMCI) raised $180 million in an initial public offering on Thursday, April 22nd 2021. The company issued 11,250,000 shares at $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Treace Medical Concepts' major shareholders? Treace Medical Concepts' top institutional investors include Gagnon Securities LLC (5.25%), Marshall Wace LLP (1.90%), State Street Corp (0.36%) and Empowered Funds LLC (0.11%). Insiders that own company stock include John T Treace, James T Treace, Richard W Mott, Sean F Scanlan and Deepti Jain. View institutional ownership trends. How do I buy shares of Treace Medical Concepts? Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Treace Medical Concepts own? Based on aggregate information from My MarketBeat watchlists, some other companies that Treace Medical Concepts investors own include CrowdStrike (CRWD), Intel (INTC), Micron Technology (MU), Newmont (NEM), UiPath (PATH), DiDi Global (DIDIY) and ARK Innovation ETF (ARKK). Company Calendar Last Earnings11/06/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 TMCI's financial health is in the Green zone, according to TradeSmith. TMCI has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TMCI CIK1630627 Webwww.treace.com Phone904-373-5940FaxN/AEmployees450Year FoundedN/APrice Target and Rating Average Price Target for Treace Medical Concepts$6.17 High Price Target$7.00 Low Price Target$5.00 Potential Upside/Downside+17.0%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.86) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$59 million Net Margins-27.44% Pretax Margin-27.44% Return on Equity-72.99% Return on Assets-29.19% Debt Debt-to-Equity Ratio0.91 Current Ratio2.58 Quick Ratio1.95 Sales & Book Value Annual Sales$212.69 million Price / Sales1.62 Cash FlowN/A Price / Cash FlowN/A Book Value$0.94 per share Price / Book5.61Miscellaneous Outstanding Shares65,560,000Free Float50,206,000Market Cap$345.50 million OptionableOptionable Beta1.59 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:TMCI) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMCI Stock Alerts